MEDIA RELEASE Sulzer AG
Corporate Communications Investor Relations
Stockholding Notification of the Renova Group and Sulzer Ltd Renova Group Increased its Shareholding in Sulzer Ltd to 31.2%
The Renova Group informed Sulzer Ltd that it has increased its shareholding from 27.1% up to 31.2%. The combined shareholding of Renova and Sulzer, which are considered to be a group for the purpose of disclosure of shareholdings, is 34.4%.
In accordance with the ordinance of the Takeover Chamber of the Swiss Federal Banking Commission (SFBC) dated May 29, 2008, Rz (40) to (50), the Renova Group and Sulzer Ltd are to be considered a group for the purpose of disclosures of shareholdings within the meaning of Art. 15 SESTO-FINMA. On March 27, 2009, Renova informed Sulzer Ltd that it had agreed with the issuers of the two previously announced Swaps on the following: • Spot and share forward transaction in connection with an equity swap
transaction regarding 534'190 Sulzer shares (ISIN CH0002376454) between Renova Industries and Nexgen.
• Spot and share forward transaction in connection with an equity swap
transaction regarding 870'000 Sulzer shares (ISIN CH0002376454) between Renova Industries and ABN.
Pursuant to the Swiss Federal Act on Stock Exchanges and Securities Trading, the following combined shareholdings are disclosed. Combined holding as of March 26, 2009:
Equity Securities Voting Rights Number Shares Percentage 11 774 752 11 774 752 Purchase Positions Voting Rights
1 Including 1.14% Forward Shares of Sulzer Ltd, which were listed as Financial Instruments under Purchase Positions before.
MEDIA RELEASE Winterthur, March 30, 2009 Page 2 of 2 / Renova Group Increased its Shareholding in Sulzer Ltd to 31.2% Sale Positions Voting Rights Conferred
Salve, Everest, Jollinson, Renova Industries, Renova Holding, TZ Columbus, Columbus Trust and Mr Vekselberg are herein referred to as the Renova Group. Salve Beteiligungs GmbH, Griechengasse 2, 1010 Vienna, Austria is a 100% subsidiary of Everest, Griechengasse 2, 1010 Vienna, Austria, which is a 100% subsidiary of Jollinson Holdings Limited, Nestonos 5 CY-6035 Lar-naca, Cyprus, which is a 100% subsidiary of Renova Industries, which is a 86% controlled subsidiary of Renova Holding Ltd, 2nd Terrace West Centre-ville, P.O. Box N-7755 Nassau, Bahamas. The 100% shareholder of Renova Holding is TZ Columbus Services Ltd., Pasea Estate, Road Town, Tortola, British Virgin Island as trustee of the Columbus Trust, a trust established un-der laws of Cayman Islands, whose ultimate beneficiary is Victor F. Veksel-berg, 19 Bakrushina Street, Bld. 2, Apt. 15, 113054 Moscow, Russia, and Susenbergstrasse 94, 8044 Zurich, Switzerland. The shareholder’s contact person for the present notification is David Kal-berer, 8832 Wilen, Switzerland. Contact persons at Sulzer: see below. Sulzer was founded in 1834 in Winterthur, Switzerland, and today is active in machinery and equipment manufacturing and surface engineering at over 120 locations worldwide. The divi-sions are global leaders in their respective customer segments, which include the oil and gas, hydrocarbon processing, power generation, pulp and paper, aviation and automotive industries. www.sulzer.com Sulzer celebrates its 175 years anniversary in 200 Inquiries: Media Relations: Verena Gölkel, Media Spokesperson Phone +41 52 262 26 82, Fax +41 52 262 00 25, [email protected]Investor Relations: Philippe Dewitz, Head of Investor Relations Phone +41 52 262 20 22, Fax +41 52 262 00 25, [email protected]
Disciplines related to visual psychophysics and perception Speaker: Lothar Spillmann September 29, 2009 Visual psychophysics encompasses the beginning and the end of the visual processing chain. This is a great opportunity to learn more about the disciplines that deal with the intermediate stages. Let us start with the very beginning, dioptrics. Here, you want to understand how an i
Metformin 2 Tage präop. absetzen, am OP-Tag kein Insulin und keine an- deren Antidiabetika 1 PRÄOPERATIV Sonstige Dauermedikation fortsetzen bis zum Tag vor OP, ggf. Rücksprache mit Stationsarzt und/oder Anästhesist 1 a OP-Indikation: 1 d Visite Klärung im kardiochirurgischen-kardiologischen KolloquiumUnterrichtung des Patienten über den Ablauf und die Vorbereitungen, Be- 1 b